Certara software takes drug toxicity to heart

Certara has beefed up its software and consulting offerings for testing potential threats of experimental drugs to the heart. The St. Louis-based company has rolled out a product called Cardiac Safety Simulator, which uses a computer-based model of human heart cells. Cardiac safety is one of the biggest areas of concern among regulators, who won't hesitate to shoot down a drug candidate or marketed product whose adverse effects on the heart outweigh its benefits. Release

Suggested Articles

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

Elligo Health Research will test a harmonized real-word data model built by the FDA.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.